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Summary 
This paper presents a new laryngoscope that includes in the handler a custom made force sensor. 
The device connects to a computer using a wireless communication and is able to generate 
sound feedback in real-time to help the practitioner. 
To access the importance of the force feedback, forty-two anaesthetists performed two series 
of laryngoscopies, with and without the audible signal, in a manikin. Maximum peak force, 
laryngoscopy time, experience and gender of the operator were registered. Comparing the 
laryngoscopies without and with the audible signal, it was observed a reduction of the maximum 
force (40.6 N vs 31.0 N; p<0.001), shorter laryngoscopy time with an average decrease of 8 
seconds (p<0.001) and lower force for the most experienced (p=0.019). Results suggest that 
when the digital laryngoscope with an audible signal is used, alerting to the applied force, the 
anaesthetist executes laryngoscopy with lower force. 
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The airway management is a constant concern for the anaesthetist [1], since failure in this 
process can increase mortality and morbidity [2]. In many situations it is imperative the use of 
tracheal intubation, despite the emergence of new techniques for handling with the airway [2].   
The conventional laryngoscopy remains the fastest and economical technique to achieve 
tracheal intubation [3]. However both, intubation and laryngoscopy, can induce hemodynamic 
alterations such as tachycardia, cranio-cervical extension, leading to increased intracranial 
hypertension, soft tissue trauma and dental injuries [4, 5]. Cardiovascular alterations related to 
laryngoscopy may be proportional to the force applied to the tongue base and supraglotic tissues 
[4]. 
The force applied during laryngoscopy is influenced by the professional’s experience and 
technique and by factors related with the patient, such as age, weight, height, length of the 
maxillary incisors and the application of manual in-line stabilization [4].  
Nowadays, there are a lot of different devices for handling airway that may induce different 
hemodynamic responses [6]. Although, a previous study that compared hemodynamic 
alterations with GlideScope® videolaryngoscopy (GSVL) and Macintosh direct laryngoscopy 
(MDLS), had demonstrated that the GSVL had no advantages over MDLS in attenuating the 
hemodynamic responses to orotracheal intubation [6]. 
Silva A. et al [7] developed a new digital laryngoscope that is capable of measuring the force 
applied during laryngoscopy. This new digital laryngoscope connects with the common blades 
to eliminate the necessity of inserting any sensor in the laryngoscope blade like in other studies 
[8]. This aspect represents a great improvement compared with the existing solutions since it 
can be used consecutively by only replacing the laryngoscope blade.  
The main goal of this study was to compare the force changes during the laryngoscopy 
procedure with and without audible force feedback mechanism. For this purpose it was used a 
new Laryngoscope (WO2014109659 A1) capable of measuring the force in real time and 
produce a sound to alert the user when an excessive force is applied. 
 
 
 
 
 
 
 
Methods 
The participants performed laryngoscopies on the manikin used for handling airway (Ambu 
type 186000; serial number 61380847F; Made in Denmark). 
The “Digital Laryngoscope” [7] was used with blade Macintosh number 3 and powered by a 
3V battery; the illumination source was replaced by a white LED. This model is 12 mm longer 
and 1.7 mm larger in diameter than a conventional handle, figure 1 [7]. The laryngoscope handle 
includes a custom load cell in the interior to measure the force applied in the laryngoscope 
blade. The measured force is transmitted to a computer using a wireless protocol – Bluetooth - 
and saved using a LabVIEW custom-made application. The computer program analyses the 
data and produces an audible signal (AS) with a frequency from 0 Hz (for 0 Newton force) 
increasing 1000Hz for each 10N of additional force. 
During the tests, each participant performed six laryngoscopies using the digital laryngoscope 
with modified handle: the first three without AS and the last three with AS.  
In the last test of each series, the applied force was measured during laryngoscopy, and the time 
required to visualize the vocal cords was registered. The gender and experience of the operator 
that performs the laryngoscopy was also collected. 
After the laryngoscopies, it was asked to the participants if they noticed changes in the light of 
the new digital laryngoscope. Then they ranked from 0 to 10 the light by comparing the 
conventional with the new laryngoscope, figure 2 [7]. The software that recorded the data from 
the laryngoscopy has also the ability to analyse the recorded data and visualize the entire 
procedure [7]. During the analyses, this software was used to obtain the maximum force 
obtained with (appendice 1a) and without AS (appendice 1b) and the time of laryngoscopy. The 
mean value and standard-deviation (SD) was also calculated for the above referred variables. 
T Student's test was used to compare the group with and without AS according to peak 
maximum force, laryngoscopy time and conventional / digital light. Normality was tested with 
Kolmogorov-Smirnov/Lilliefors test. 
A Multivariable linear regression analysis was performed to estimate the effect of experience 
and gender in the average maximum force and laryngoscopy duration. Results of these models 
are shown using β coefficients with 95% confidence intervals (95% CI). 
 
 
All statistical analysis was calculated with the software Statistical Package for the Social 
Sciences (SPSS) version 22.0 (IBM, Amarte, NY, USA). A value of p < 0.05 was considered 
statistically significant.  
 
Results  
For this study were recruited forty-two anaesthetists from a university hospital, including 
specialists and residents in anaesthesia to perform two series of classic direct laryngoscopies. 
Seven participants were excluded due to incomplete data, remaining 35 anaesthetists records.  
As it can be seen in figure 3, the mean maximum force during intubation with the digital 
laryngoscope with audible signal off was 40.6 N (SD=11.4), whereas with it on was 31.0 N 
(SD=7.5). The difference between the mean maximum forces of 9.6 N is statistically significant 
(p<0.001). The average time of laryngoscopy with the digital laryngoscope with AS off was 28 
seconds (SD=14) and with it on was 20 seconds (SD=11). The difference between these two 
sets, of 8 seconds, was statistically significant (p<0.001). As described in table 1, the more is 
the anaesthetist’s experience, the lower is the mean difference of the maximum force during 
laryngoscopy with and without AS (p=0.019 β=-0.284; 95% CI: -0.518;-0.051). 
The gender of the operator has no influence on the mean difference peak maximum force made 
during the laryngoscopy (p=0.079). The anaesthetist’s experience and gender did not 
influenced the time of the laryngoscopy (p=0.649 and p=0.301, respectively). 
Concerning the light, all anaesthetists preferred the digital laryngoscope to the conventional. In 
figure 2 is compared the light visibility [7]. The mean rating on the digital was 9.10/10 
(SD=0.672), while the mean of rating of the conventional was 6.54/10 (SD=1.491). This rating 
difference was also statistically significant (p=0.038). The light rating was not affected by the 
years of experience (p=0.401) neither the gender of the operator (p=0.217). 
 
 
 
 
 
 
 
 
Discussion 
The force applied during laryngoscopy can induce hemodynamic alterations [4] and it increases 
the risk of dental injury and consequently the risk of aspiration [5]. These are the most common 
incident reported [5].  
The previous studies use very thin force sensors, commonly flexiforce from teckscan® [8]. 
However, these sensors lack of the repeatability and precision when compared with the 
developed custom load cell [9]. Furthermore, they set a small sensitive area in the laryngoscope 
blade which may not represent the amount of force applied to the patient. Instead, in the digital 
laryngoscope is measured the total force applied to the blade. 
The sound warning from the digital laryngoscope, at first impression, can be viewed as a 
disadvantage for some users since they may be distracted from the critical laryngoscopy 
procedure. However, this was not reported from any of the subjects that performed the test. The 
audible signal proved to be an advantage: when the anaesthetist uses a digital laryngoscope with 
an AS alerting to the force applied, he executes a laryngoscopy with lower force in a shorter 
time. 
Fukuda T. et al. [5] studied the force applied to the maxillary incisors during direct 
laryngoscopy when performed by experienced anaesthetists and residents in anaesthesia. It was 
demonstrated in this study that the experience level of the anaesthetists influenced both, peak 
force and the laryngoscopy time required. In our study also experienced users applied lower 
force. More precisely, the average of the average maximum force at the laryngoscopy was only 
76% of the force required without audible signal. For the time of intubation, it was observed a 
reduction of 8 seconds by turning on the audible signal, representing a reduction of 30%. 
Notably, the anaesthetists preferred the light from the digital laryngoscope than the 
conventional to see the vocal cords, as the light is brighter and white.  
The handle of the new digital laryngoscope is slightly heavier than the conventional, although 
the participants did not report any discomfort or inconvenient.  
There are many factors related to patients that influence the force applied during laryngoscopy 
[4] such as height, weight, age, gender and the presence of maxillary incisors [5]. To overcome 
heterogeneity of the patients, it was used a manikin, allowing the evaluation of the anaesthetist’s 
ability.  
 
 
It would be important in the future to develop the same concept in videolaryngoscopy to 
compare the same parameters and to establish which one needs less force.  
In conclusion, our study showed that anaesthetists need less force and shorter time to perform 
the laryngoscopy with the new digital laryngoscope with the audible signal on.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendice 1 Laryngoscopy data. 
 
a) Maximum force in laryngoscopy with AS (23.2 N) 
 
 
 
 
 
b) Maximum force in laryngoscopy without AS (25.6 N) 
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Table 1 – Factors associated with mean differences between maximum peak force of the digital 
laryngoscope during laryngoscopy with audible signal (AS) on and off, laryngoscopy time with 
AS on and off and conventional or digital light rating. 
 Peak maximum force Laryngoscopy time Light rating 
 β coef. (95% CI) P value β coef. 95% CI P value β coef. 95% CI Pvalue 
Gender       
Female 1  1  1  
Male 5.364 (0.664;11.392) 0.079 4.532 (-4.268; 13.332) 0.301 0.631 (-0.388;1.649) 0.217 
Year’s experience -0.284 (-0.51;-0.051) 0.019 0.075 (-0.257;0.406) 0.649 0.016 (-0.023;-0.055) 0.401 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Left – Standard laryngoscope; Right – Digital laryngoscope [7] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Light visibility comparison [7] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Mean difference between A) maximum forces with and without audible signal (AS); 
B) laryngoscopy time with and without AS; C) conventional and digital light rating (bars 
represent standard deviation of the mean). 
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explained as footnotes in the order in which they are first mentioned, using the following symbols (nb not 
superscript) in the following order: *, †, ‡, §, ¶, **, ††, ‡‡, etc. The study groups should form the columns 
rather than the rows. If statistical comparisons are being made, a separate column with exact p values 
should appear. 
Example: 
 
Figures 
Please supply each Figure as a separate file, rather than embed them within the body of the Word 
document, and preferably in TIFF or high-resolution JPEG format. We ask that they are both supplied at a 
resolution of 300 pixels per inch for photographs and 600 pixels per inch for line art or a combination of 
photograph and labelling. Please do not send image files larger than 10MB. 
Please ensure related graphs have the same format (fonts, use of symbols, etc), and that the groups are 
presented in the same order in each graph (and in the same order as in the rest of the manuscript). The 
same requirements for abbreviations and units apply as for those in the text. The title, plot frame, gridlines 
and legend box within the graph itself should be removed, with symbols and error bars explained in the 
Caption. Avoid the use of 3-D unless absolutely necessary. Please note that colour Figures (e.g. 
photographs, complex flow diagrams, etc) may be used without charge, but only if the Editors consider that 
the use of colour is crucial. 
Captions for Figures 
Each Figure Caption should include an explanation of the symbols used to provide enough information for 
readers to follow it without having to look through the text. 
Thus this: 
 
Figure 1 Itching after surgery in patients receiving saline ( ) or chlorphenamine ( ). No significant difference 
between groups. 
Is preferable to this: 
 Figure 1 Itching after surgery. 
 
See notes below for ethical considerations relating to photographs. 
Supporting Information (online only) 
Additional material such as video clips, lengthy Appendices (e.g. extensive reference lists or mathematical 
formulae/calculations), etc, that are relevant to a particular article but not suitable or essential for the print 
edition of the Journal, may also be considered for publication. Please refer to all supporting information in 
the manuscript using Table S1, Figure S1, etc, and supply such information as separate files (i.e. not 
embedded within the main manuscript). Further information on suitable file formats etc may be found here 
Language 
Please note that Anaesthesia uses UK English spelling eg “ise” not “ize”, “anaes” not “anes” etc. In 
general, we prefer a clear, precise style to jargon. Please avoid long, complicated sentences and the 
passive voice when the active is more appropriate (e.g. ‘We chose epidural anaesthesia because...’ 
instead of ‘Epidural anaesthesia was chosen by the authors because...’). Remove unnecessary clutter and 
focus on the actual message of each sentence; thus ‘Hypotension is important because...’ instead of ‘It 
would be remiss of us not to mention hypotension because...’). Remember that lungs are ventilated, not 
patients (nor are they intubated – their tracheas are). Similarly, patients are not induced – anaesthesia is – 
or put on ventilators. Correct terms are tracheal (not endotracheal) tube and neuromuscular blocking 
drugs (not muscle relaxants). Please refer to recent issues of the Journal for preferred wording/spelling, 
e.g. “manikin” is preferred to “mannequin”, and “supraglottic airway device” is preferred to “extraglottic 
airway device”. 
Abbreviations 
In general, the Journal does not encourage the use of abbreviations, especially in the Summary, since 
their frequent use makes papers cluttered and difficult to read. However, we will accept abbreviations in 
the following circumstances: 
 Universal abbreviations that do not need to be written out in full when first mentioned in the text. 
These include abbreviations that appear in a large proportion of the articles published in the Journal, 
e.g. ASA, BMI, ECG, ICU, HDU, SD, SEM, 95% CI, IQR, ANOVA, SpO2, FIO2, pH. 
 Acceptable common abbreviations that can be used but should be written out in full at their first 
mention, e.g.: CNS, CSF, HME, PEEP, PCA, SCBU, CTG, EEG, BIS, CVP, PAP, PCWP, ECT – 
unless they’re only mentioned a few times, in which case please spell them out throughout. Please 
do not use abbreviations that are clumsy or will be unfamiliar to the majority of readers, e.g. DI 
(difficult intubation), TTFB (time to first breath), etc 
 Acceptable abbreviations that do not need to be written out in full when first mentioned but whose 
use should be restricted to situations where space is limited, such as in formulae or in Tables and 
Figures, e.g.: O2, CO2, N2O, HCO3-, Na+, K+, Mg2+. 
Numbers and units 
Numbers should be spelled out in full when they start a sentence, and when they are less than 10 (unless 
they are followed by units of measurement). Thus: ‘Thirteen days later, five patients each received 7 ml 
solution...’ Commas are not used to indicate thousands; thus 2000 and 20 000 instead of 2,000 and 
20,000. Please give costs in sterling (£) with equivalent Euros and US dollars (€/$) in brackets. 
 
Use the format mg.kg-1 not mg/kg for all units. Use SI units throughout the text except for vascular pressure 
measurements (mmHg or cmH2O) and haemoglobin concentration (g.l-1). Litres are indicated by lower case 
‘l’ not upper ‘L’. Use the 24-hour clock for times. 
 
Ethical considerations 
Whatever their other merits, manuscripts will only be considered for publication in Anaesthesia if they 
adhere to the highest ethical standards. These are detailed in two editorials published in the journal, that 
are available here and here and which potential authors are strongly advised to consult. In brief: 
 Approval by a Research Ethics Committee (REC) or equivalent (e.g. Institutional Review Board) must 
be obtained prospectively for all studies on human subjects, including studies in which participants’ 
skills are tested using manikins. While some audit and epidemiological surveys, some assessments 
of medical equipment, and some studies involving NHS staff may be exempt from this stricture if 
participants are appropriately protected against coercion and there is due regard to confidentiality, 
publication of the results would usually still require informed consent and assurances regarding 
confidentiality (including approval by theCaldicott Guardian for patient data in the NHS, or equivalent 
if not), even if the REC and/or R&D Department has indicated that formal submission is unnecessary. 
 While an essential preliminary step, REC approval does not guarantee that the ethical standards of a 
study will meet the requirements of the Editorial Board of Anaesthesia. If authors have any concerns 
that ethical issues might compromise publication, they are invited to contact the Editor-in-Chief 
before embarking on the study. 
 The Editorial Board supports the view of the General Medical Council that full prospective written 
informed consent should be obtained from all subjects of clinical trials, including participants in 
manikin studies (see above). As incorporated in regulatory procedures around the world, e.g. in The 
International Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use (ICH) international standards ‘Good Clinical Practice’, this would 
normally comprise provision of written information to potential research participants, allowance of 
adequate time for them to consider their involvement and ask questions, and the use of specific 
consent forms (for the study, not just for routine surgery/anaesthesia) that should be signed by the 
participants to indicate their consent and then stored in case they require examination later. Authors 
who do not follow this guidance will need to be able to mount a robust defence of their decision. 
 Submission of a case report requires the written consent of the subject to publication, using the 
specific form which may be found here (NB please do not submit this document together with your 
manuscript/Declaration Form – though please note that authors may be asked to provide the signed 
form as evidence, should a complaint result in a subsequent investigation). While the Editorial Board 
recognises that it might not always be possible to seek such consent (or the assent of the next-of-kin 
if the patient has died), the onus will be on the authors to demonstrate that this exception applies in 
their case. Please state in an Acknowledgement at the end of the text: ‘Published with the written 
consent of the patient(s)’ or similar, as appropriate. 
  
 Studies of novel treatments, in particular drug studies where the agent used is given via unlicensed 
routes (especially spinal and epidural), may have received approval from the REC or equivalent, but 
the Editorial Board is likely to reject such studies if it considers that the risks posed outweigh the 
potential benefits. Such a conclusion is more likely to be reached if the drug in question is not widely 
used in routine practice (as evidenced by inclusion in standard textbooks), if the study participants 
are especially vulnerable (e.g. children, women in labour), if there are questions over consent, or if 
only modest improvements in outcome are expected where other, well established methods already 
exist. 
 Animal studies will only be considered for publication if they have ethical and Home Office (or local 
equivalent) approval, and have been conducted under appropriate standards of care. Researchers 
will be expected to follow the ARRIVE guidelines for experimentation in animal research. 
Statistics 
The following guidelines have been prepared by the Editorial Board of Anaesthesia to help authors avoid 
the common statistical errors that frequently lead to rejection of work submitted for publication. This should 
not be regarded as an exhaustive list and, of course, the Editorial Board and reviewers of manuscripts may 
ask authors for revisions that are not detailed here. However, adherence to these guidelines in a paper 
that is otherwise acceptable will give researchers a good chance of publication and help ensure that their 
work is statistically valid. 
 
Methods 
Randomisation methods must minimise the possibility of predicting or breaking the code. 
Blinding must be as good as possible. 
Where there are several outcomes to be reported, the most important (primary) outcome should be clearly 
stated. 
 
Power analysis: 
 Justification of sample size should always be performed before randomised controlled trials are 
started. Details provided should include the power level; the significance level at which a result is 
sought; and the expected control and study group proportions or mean and pooled SD, in order to 
allow reviewers and readers to follow the calculation. 
 The power of study should be at least 80%. 
 The ‘clinically important difference’ that the study is designed to detect should be clinically relevant 
and should not be set unreasonably large (sometimes done to justify small sample size). 
Descriptive statistics: 
 Use mean (SD) unless: 
 Data are discrete (e.g. Apgar scores, sedation scores) or grossly non-normally distributed: use 
median (IQR [range]). 
 You are interested in the ‘true’ value for the population (use SEM). 
 Visual analogue scores (VAS) for pain may be treated as continuous data and be subjected to 
parametric tests as long as: 
 The sample size is large (> 50). 
 The data appear normally distributed. 
 VAS for other modalities (nausea, drowsiness) have not been so extensively validated and are best 
treated as ordinal data. 
Inferential statistics: 
 Use simple tests where possible. 
 Avoid multiple comparisons, or correct for them if used. 
 Reference unusual tests. 
 Include details of any computer package/version used. 
When looking for relationship between variables: 
 Possible simple descriptive association between two variables: correlation. 
 Possible relationship between two or more variables, especially where one is predictive and other(s) 
dependent: regression. 
 To compare two methods of measurement: Bland-Altman method. 
 
Results 
 In randomised trials, baseline data (age, ASA physical status, duration of operation, etc.) should not 
be subjected to statistical comparison, since it is already known that the subjects were randomly 
allocated and that any difference is therefore due to chance. Describe characteristics and, if possible, 
allow for differences in the analysis and discussion. 
 All outcomes mentioned in the Methods section must be reported in the Results section, and in the 
same order. 
 The number of decimal places used to describe data should be appropriate to the method of 
measurement (e.g. a mean systolic blood pressure of 124.75 mmHg is too precise). 
 95% CI are often useful when reporting differences between groups. 95% CI must be used when 
reporting low or zero incidences (e.g. no headaches after 300 uses of a new spinal needle). 
 When reporting the effect of an intervention, absolute risk (AR), relative risk (RR) and ‘number 
needed to treat’ (NNT) are more easily understood by readers and may be preferable to odds ratio 
(OR). 
 Post-hoc comparisons should be avoided (comparing or categorising results in ways that were not 
stated in the original protocol). 
 Graphs and tables should be appropriate for the data to be displayed. Tables usually convey more 
precise numerical information; graphs should be reserved for highlighting changes over time or 
between treatments. 
 Avoid judgemental terms such as ‘very’ or ‘highly’ significant. 
 Report actual p values, rather than ranges or limits (e.g. p=0.032, rather than p<0.05) 
 
Conclusions 
All conclusions should be warranted by the results and not extend beyond the confines of the study 
conditions. A negative result does not mean that there is definitely no difference (confidence in the 
conclusion is dependent upon the power of the study), and a positive result does not mean that there 
definitely is a difference (confidence in the conclusion is dependent upon the alpha error). 
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Apêndices 
UM NOVO LARINGOSCÓPIO QUE ALERTA O 
ANESTESIOLOGISTA PARA A FORÇA APLICADA 
 
Tânia Amaral1, Mariana Duarte2, António Silva3, Joaquim Gabriel Mendes3, Joana Mourão1,2 
1 Serviço de Anestesiologia do Centro Hospitalar de São João, EPE; 2 Faculdade de Medicina da Universidade do Porto;  
3 Faculdade de Engenharia da Universidade do Porto  
        A laringoscopia direta convencional continua a ser a técnica de manuseamento da via 
aérea mais rápida e económica para se conseguir entubação traqueal1.  
        Desenvolveu-se um laringoscópio digital (Fig. 1) com um sensor de força embutido no 
cabo que deteta a força aplicada na base da língua durante a laringoscopia. O sensor está 
acoplado a um sinal sonoro (SS) cuja frequência aumenta 1000 Hertz (Hz) por cada 
aumento de 10 Newton (N) na força aplicada 2.  
       O objectivo deste estudo foi comparar a força aplicada pelo anestesiologista durante a 
laringoscopia quando utiliza o laringoscópio digital com o SS ligado e desligado. 
  
• Realização de duas séries de 3 laringoscopias com o laringoscópio digital, com e 
sem SS, efetuadas num manequim de manuseio da via aérea.  
• Foram registados os seguintes dados da última laringoscopia de cada série:  
• pico de força máximo, 
• tempo da laringoscopia,  
• anos de experiência e o género dos operadores.  
• Análise estatística: Teste T Student, Teste Kolmogorov-Smirnov/Lilliefors e 
Análise regressiva linear. A significância estatística foi definida para p<0.05. 
       Participaram 42 Anestesiologistas dos quais 7 foram excluídos por registos 
incompletos. 
 
         Os nossos resultados sugerem que quando o anestesiologista utiliza um 
laringoscópio que o alerta para a força exercida, este realiza menos força e demora 
menos tempo para executar a laringoscopia. 
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Fig. 1 : Laringoscópio  clássico 
(esquerda) e digital (direita) 
TABELA 1  
  
PICO DE FORÇA MÁXIMO TEMPO DE LARINGOSCOPIA 
β coef. (95% CI) Valor P  β coef. 95% CI Valor P  
G
ÉN
ER
O
  
FEMININO 1 1 
MASCULINO 5.364 (0.664;11.392) 0.079 4.532 (-4.268; 13.332) 0.301 
ANOS DE EXPERIÊNCIA -0.284 (-0.51;-0.051) 0.019 0.075 (-0.257;0.406) 0.649 
Estimado(a) autor(a) de resumo proposto ao congresso anual da Sociedade Portuguesa de 
Anestesiologia (SPA), a realizar nos dias 12 a 14 de Março de 2015, no Hotel Cascais Miragem. 
 
O seu resumo, identificado com o nº P117 - S6607 e com o título Um novo laringoscópio que 
alerta o anestesiologista para a força aplicada , foi aceite pelo júri nomeado pela SPA na 
categoria (preliminar) de POSTER. 
 
Conforme o regulamento, a apresentação do poster obedece às seguintes normas: 
1. No mínimo, o primeiro autor e/ou apresentador do poster terá obrigatoriamente de 
se inscrever como congressista do congresso da SPA 2015, até ao dia 27 de 
Fevereiro. A não efetivação deste requisito implicará a desclassificação automática do 
poster. 
2. As dimensões dos posters serão: Altura 1,00m; Largura 0,80m. Dispostos verticalmente. 
3. A elaboração dos posters e a forma de fixação dos mesmos é da responsabilidade dos 
autores. Sugerimos que contactem o secretariado do congresso para informações sobre 
os métodos mais adequados. 
4. Todos os posters terão se ser afixados, no local respetivo, no dia 13 de Março da parte 
da manhã até às 10h. Os congressistas que, por motivo de força maior devidamente 
justificada não o possam fazer, deverão comunicar esse facto à organização do 
congresso. 
5. Caso o autor queira distribuir "handouts" do poster, em formato A4, cuja elaboração é 
também da responsabilidade dos autores, deverá levar uma bolsa para esse efeito. 
6. Os posters serão discutidos um a um por um ou dois membros do júri, numa sessão de 
apresentação de posters 
o a. A data e hora da sessão de posters do seu poster será comunicada até ao dia 
27 de Fevereiro de 2015. 
o b. O primeiro autor ou apresentador deverá fazer uma apresentação oral do seu 
trabalho diante do poster. Esta apresentação deverá ser efetuada no máximo em 
4 minutos e será seguida de discussão num máximo de 4 minutos. 
o c. Algum impedimento do primeiro autor ou apresentador para estar presente na 
sessão de posters designada terá de ser forçosamente comunicada até ao dia (2 
dias antes), à organização do congresso. 
7. Até ao dia 27 de Fevereiro de 2015, o júri irá indicar quais os posters que serão objeto de 
comunicação oral, em formato power point, a efetuar em sessão plenária do congresso, 
no dia 14 de Março de 2015, nos mesmos moldes da apresentação do poster. 
 
Com os melhores cumprimentos, 
A coordenação do júri, 
Pedro Amorim, António Augusto Martins, Paulo Sá Rodrigues 
  
 
